Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FWUXH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,678
Award facts
- Contract value 100% obligated
- $16,678.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, with a ceiling value of $16,678.36. The delivery order, valued at approximately $16.7K, calls for the supply of Xtandi 40 mg tablets (120-count units), an oral medication used primarily in oncology treatments. This award does not utilize any set-aside designation and is expected to be completed by September 29, 2025, with performance occurring at the contractor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The contractor has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering branded and generic prescription drugs, biologics, and medical consumables. The DLA's pharmaceutical procurement through this IDC structure ensures reliable access to essential medications and supplies for military health facilities across the globe.
Quick answers
Who was awarded contract SPE2DB25FWUXH?
SPE2DB25FWUXH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FWUXH worth?
The government has obligated $16,678 on SPE2DB25FWUXH.
Is contract SPE2DB25FWUXH an order under another contract?
Yes. SPE2DB25FWUXH is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUXH competed?
The extent of competition for SPE2DB25FWUXH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award